Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: NEOPLASMS - DRUG THERAPY , . Treffer: 666

2023

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

2022

Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dankner, M; Wang, Y; Fazelzad, R; Johnson, B; Nebhan, CA; Dagogo-Jack, I; Myall, NJ; Richtig, G; Bracht, JWP; Gerlinger, M; Shinozaki, E; Yoshino, T; Kotani, D; Fangusaro, JR; Gautschi, O; Mazieres, J; Sosman, JA; Kopetz, S; Subbiah, V; Davies, MA; Groover, AL; Sullivan, RJ; Flaherty, KT; Johnson, DB; Benedetti, A; Cescon, DW; Spreafico, A; Zogopoulos, G; Rose, AAN Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol. 2022; 6:e2200107 Doi: 10.1200/PO.22.00107
Web of Science PubMed FullText FullText_MUG

 

Gulla, A; Hashimoto, D; Wagner, D; Damaseviciute, R; Strupas, K; Satoi, S Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors-Literature Review.
Medicina (Kaunas). 2022; 58(6): Doi: 10.3390/medicina58060756 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lyon, AR; López-Fernández, T; Couch, LS; Asteggiano, R; Aznar, MC; Bergler-Klein, J; Boriani, G; Cardinale, D; Cordoba, R; Cosyns, B; Cutter, DJ; de, Azambuja, E; de, Boer, RA; Dent, SF; Farmakis, D; Gevaert, SA; Gorog, DA; Herrmann, J; Lenihan, D; Moslehi, J; Moura, B; Salinger, SS; Stephens, R; Suter, TM; Szmit, S; Tamargo, J; Thavendiranathan, P; Tocchetti, CG; van der Meer, P; van der Pal, HJH; ESC Scientific Document Group 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Eur Heart J. 2022; 43(41): 4229-4361. Doi: 10.1093/eurheartj/ehac244
PubMed FullText FullText_MUG

 

Meert, AP; Toffart, AC; Picard, M; Jaubert, P; Gibelin, A; Bauer, P; Mokart, D; Van, De, Louw, A; Hatzl, S; Moreno-Gonzales, G; Rousseau-Bussac, G; Bruneel, F; Montini, L; Moreau, AS; Carpentier, D; Seguin, A; Hemelaar, P; Azoulay, E; Lemiale, V When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Bull Cancer. 2022; 109(9):916-924 Doi: 10.1016/j.bulcan.2022.04.014
Web of Science PubMed FullText FullText_MUG

 

2021

Geiger-Gritsch, S; Olschewski, H; Kocher, F; Wurm, R; Absenger, G; Flicker, M; Hermann, A; Heininger, P; Fiegl, M; Zechmeister, M; Endel, F; Wild, C; Pall, G Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter study.
Wien Klin Wochenschr. 2021; 133(21-22):1122-1130 Doi: 10.1007/s00508-021-01940-w
Web of Science PubMed FullText FullText_MUG

 

Moik, F; Chan, WE; Wiedemann, S; Hoeller, C; Tuchmann, F; Aretin, MB; Fuereder, T; Zöchbauer-Müller, S; Preusser, M; Pabinger, I; Ay, C Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Blood. 2021; 137(12):1669-1678 Doi: 10.1182/blood.2020007878 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Al-Zoughbi, W; Hoefler, G Tumor Macroenvironment: An Update.
Pathobiology. 2020; 87(2):58-60 Doi: 10.1159/000502097 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bjelic-Radisic, V; Cardoso, F; Cameron, D; Brain, E; Kuljanic, K; da Costa, RA; Conroy, T; Inwald, EC; Serpentini, S; Pinto, M; Weis, J; Morag, O; Lindviksmoen Astrup, G; Tomaszweksi, KA; Pogoda, K; Sinai, P; Sprangers, M; Aaronson, N; Velikova, G; Greimel, E; Arraras, J; Bottomley, A; EORTC Quality of Life Group and Breast Cancer Group An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
Ann Oncol. 2020; 31(2):283-288 Doi: 10.1016/j.annonc.2019.10.027
Web of Science PubMed FullText FullText_MUG

 

Caratelli, S; Arriga, R; Sconocchia, T; Ottaviani, A; Lanzilli, G; Pastore, D; Cenciarelli, C; Venditti, A; Del Principe, MI; Lauro, D; Landoni, E; Du, H; Savoldo, B; Ferrone, S; Dotti, G; Sconocchia, G In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Int J Cancer. 2020; 146(1):236-247 Doi: 10.1002/ijc.32663 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106 Doi: 10.1016/j.ejca.2020.04.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Elbelt, U; Schlaffer, SM; Buchfelder, M; Knappe, UJ; Vila, G; Micko, A; Deutschbein, T; Unger, N; Lammert, A; Topuzoglu-Müller, T; Bojunga, J; Droste, M; Johanssen, S; Kolenda, H; Ritzel, K; Buslei, R; Strasburger, CJ; Petersenn, S; Honegger, J Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.
J Clin Endocrinol Metab. 2020; 105(3): Doi: 10.1210/clinem/dgz211
Web of Science PubMed FullText FullText_MUG

 

Hurvitz, SA; Martin, M; Press, MF; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Barriga, S; Wijayawardana, S; Brahmachary, M; Ebert, PJ; Hossain, A; Liu, J; Abel, A; Aggarwal, A; Jansen, VM; Slamon, DJ Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR⁺/HER2^- Breast Cancer.
CLIN CANCER RES. 2020; 26(3): 566-580. Doi: 10.1158/1078-0432.CCR-19-1425 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lord, SR; Collins, JM; Cheng, WC; Haider, S; Wigfield, S; Gaude, E; Fielding, BA; Pinnick, KE; Harjes, U; Segaran, A; Jha, P; Hoefler, G; Pollak, MN; Thompson, AM; Roy, PG; English, R; Adams, RF; Frezza, C; Buffa, FM; Karpe, F; Harris, AL Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin.
Br J Cancer. 2020; 122(2):258-265 Doi: 10.1038/s41416-019-0665-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
Thromb Res. 2020; 187:9-17 Doi: 10.1016/j.thromres.2020.01.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Musoro, JZ; Coens, C; Greimel, E; King, MT; Sprangers, MAG; Nordin, A; van Dorst, EBL; Groenvold, M; Cocks, K; Velikova, G; Flechtner, HH; Bottomley, A; EORTC Gynecological and Quality of Life Groups Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
GYNECOL ONCOL. 2020; 159(2): 515-521. Doi: 10.1016/j.ygyno.2020.09.007
Web of Science PubMed FullText FullText_MUG

 

Mynarek, M; von Hoff, K; Pietsch, T; Ottensmeier, H; Warmuth-Metz, M; Bison, B; Pfister, S; Korshunov, A; Sharma, T; Jaeger, N; Ryzhova, M; Zheludkova, O; Golanov, A; Rushing, EJ; Hasselblatt, M; Koch, A; Schüller, U; von Deimling, A; Sahm, F; Sill, M; Riemenschneider, MJ; Dohmen, H; Monoranu, CM; Sommer, C; Staszewski, O; Mawrin, C; Schittenhelm, J; Brück, W; Filipski, K; Hartmann, C; Meinhardt, M; Pietschmann, K; Haberler, C; Slavc, I; Gerber, NU; Grotzer, M; Benesch, M; Schlegel, PG; Deinlein, F; von Bueren, AO; Friedrich, C; Juhnke, BO; Obrecht, D; Fleischhack, G; Kwiecien, R; Faldum, A; Kortmann, RD; Kool, M; Rutkowski, S Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
J Clin Oncol. 2020; 38(18):2028-2040 Doi: 10.1200/JCO.19.03057
Web of Science PubMed FullText FullText_MUG

 

Scherr, AL; Mock, A; Gdynia, G; Schmitt, N; Heilig, CE; Korell, F; Rhadakrishnan, P; Hoffmeister, P; Metzeler, KH; Schulze-Osthoff, K; Illert, AL; Boerries, M; Trojan, J; Waidmann, O; Falkenhorst, J; Siveke, J; Jost, PJ; Bitzer, M; Malek, NP; Vecchione, L; Jelas, I; Brors, B; Glimm, H; Stenzinger, A; Grekova, SP; Gehrig, T; Schulze-Bergkamen, H; Jäger, D; Schirmacher, P; Heikenwalder, M; Goeppert, B; Schneider, M; Fröhling, S; Köhler, BC Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.
Cell Death Dis. 2020; 11(10):875 Doi: 10.1038/s41419-020-03092-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwaab, J; Naumann, N; Luebke, J; Jawhar, M; Somervaille, TCP; Williams, MS; Frewin, R; Jost, PJ; Lichtenegger, FS; La Rosée, P; Storch, N; Haferlach, T; Horny, HP; Fabarius, A; Haferlach, C; Burchert, A; Hofmann, WK; Cross, NCP; Hochhaus, A; Reiter, A; Metzgeroth, G Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol. 2020; 95(7):824-833 Doi: 10.1002/ajh.25825 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52 Doi: 10.1016/j.ejca.2020.03.018
Web of Science PubMed FullText FullText_MUG

 

Steger, GG; Egle, D; Bartsch, R; Pfeiler, G; Petru, E; Greil, R; Helfgott, R; Marth, C; Öhler, L; Hubalek, M; Lang, A; Tinchon, C; Haslbauer, F; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Gnant, M Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Breast. 2020; 50:64-70 Doi: 10.1016/j.breast.2020.01.035 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bollerslev, J; Schalin-Jantti, C; Rejnmark, L; Siggelkow, H; Morreau, H; Thakker, RV; Sitges-Serra, A; Cetani, F; Marcocci, C; PARAT Workshop Group MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.
EUR J ENDOCRINOL. 2019; 181(3): P1-P19. Doi: 10.1530/EJE-19-0316 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kargl, J; Zhu, X; Zhang, H; Yang, GHY; Friesen, TJ; Shipley, M; Maeda, DY; Zebala, JA; McKay-Fleisch, J; Meredith, G; Mashadi-Hossein, A; Baik, C; Pierce, RH; Redman, MW; Thompson, JC; Albelda, SM; Bolouri, H; Houghton, AM Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC.
JCI Insight. 2019; 4(24): Doi: 10.1172/jci.insight.130850 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedmann, K; Bassermann, F; Jost, PJ [Kinase inhibitors in oncology : What is new?]
Internist (Berl). 2019; 60(5):540-544 Doi: 10.1007/s00108-019-0577-8
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498 Doi: 10.1097/RCT.0000000000000848
Web of Science PubMed FullText FullText_MUG

 

Vieyra-Garcia, P; Fink-Puches, R; Porkert, S; Lang, R; Pöchlauer, S; Ratzinger, G; Tanew, A; Selhofer, S; Paul-Gunther, S; Hofer, A; Gruber-Wackernagel, A; Legat, F; Patra, V; Quehenberger, F; Cerroni, L; Clark, R; Wolf, P Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
JAMA Dermatol. 2019; 155(5):538-547 Doi: 10.1001/jamadermatol.2018.5905 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Vo, DH; Hartig, R; Weinert, S; Haybaeck, J; Nass, N G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
Biomolecules. 2019; 9(9): Doi: 10.3390/biom9090503 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I [Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366 Doi: 10.1007/s00105-019-4359-y (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Alvarez, MJ; Subramaniam, PS; Tang, LH; Grunn, A; Aburi, M; Rieckhof, G; Komissarova, EV; Hagan, EA; Bodei, L; Clemons, PA; Dela Cruz, FS; Dhall, D; Diolaiti, D; Fraker, DA; Ghavami, A; Kaemmerer, D; Karan, C; Kidd, M; Kim, KM; Kim, HC; Kunju, LP; Langel, U; Li, Z; Lee, J; Li, H; LiVolsi, V; Pfragner, R; Schwach, G; Rainey, AR; Realubit, RB; Remotti, H; Regberg, J; Roses, R; Rustgi, A; Sepulveda, AR; Serra, S; Shi, CJ; Yuan, XP; Barberis, M; Bergamaschi, R; Chinnaiyan, AM; Detre, T; Ezzat, S; Frilling, A; Hommann, M; Jaeger, D; Kim, MK; Knudsen, BS; Kung, AL; Leahy, E; Metz, DC; Milsom, JW; Park, YS; Reidy-Lagunes, D; Schreiber, S; Washington, K; Wiedenmann, B; Modlin, I; Califano, A A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
Nat Genet. 2018; 50(7):979-989 Doi: 10.1038/s41588-018-0138-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Buder, A; Hochmair, MJ; Schwab, S; Bundalo, T; Schenk, P; Errhalt, P; Mikes, RE; Absenger, G; Patocka, K; Baumgartner, B; Setinek, U; Burghuber, OC; Prosch, H; Pirker, R; Filipits, M Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
J Thorac Oncol. 2018; 13(6):821-830 Doi: 10.1016/j.jtho.2018.02.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cserni, G; Zombori, T; Andreu, X; Bianchi, S; Regitnig, P; Amendoeira, I; Balmativola, D; Kovács, A; Cordoba, A; Reiner, A; Kulka, J; Kaya, H; Liepniece-Karele, I; Quinn, C; Kővári, B Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Pathol Oncol Res. 2018; 24(1):167-170 Doi: 10.1007/s12253-017-0229-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fuchs, R; Stracke, A; Holzmann, V; Luschin-Ebengreuth, G; Meier-Allard, N; Ebner, N; Lassacher, TM; Absenger-Novak, M; Fröhlich, E; Schittmayer, M; Cano Crespo, S; Palacin, M; Rinner, B; Birner-Gruenberger, R Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc.
Biochim Biophys Acta Mol Cell Res. 2018; 1865(9):1211-1229 Doi: 10.1016/j.bbamcr.2018.06.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gandhi, L; Rodríguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SY; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC; KEYNOTE-189 Investigators Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018; 378(22): 2078-2092. Doi: 10.1056/NEJMoa1801005
Web of Science PubMed FullText FullText_MUG

 

Giuffrida, R; Kashofer, K; Dika, E; Patrizi, A; Baraldi, C; Di Meo, N; Zalaudek, I Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases.
Eur J Cancer. 2018; 91(2):177-179 Doi: 10.1016/j.ejca.2017.11.031 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Hann, A; Nosalski, E; Hermann, PC; Egger, J; Seufferlein, T; Keller, F Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Clin Nephrol. 2018; 90(2):125-141 Doi: 10.5414/CN109327
Web of Science PubMed FullText FullText_MUG

 

Jahanafrooz, Z; Stallinger, A; Anders, I; Kleinegger, F; Lohberger, B; Durchschein, C; Bauer, R; Deutsch, A; Rinner, B; Kretschmer, N Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.
Phytomedicine. 2018; 49(11):32-40 Doi: 10.1016/j.phymed.2018.06.005
Web of Science PubMed FullText FullText_MUG

 

Kreuter, A; Pantelaki, I; Michalowitz, AL; Wieland, U; Cerroni, L; Oellig, F; Tigges, C CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.
Clin Exp Dermatol. 2018; 43(5):585-588 Doi: 10.1111/ced.13416 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Läubli, H; Balmelli, C; Kaufmann, L; Stanczak, M; Syedbasha, M; Vogt, D; Hertig, A; Müller, B; Gautschi, O; Stenner, F; Zippelius, A; Egli, A; Rothschild, SI Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.
J Immunother Cancer. 2018; 6(1): 40-40. Doi: 10.1186/s40425-018-0353-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leitinger, M; Varosanec, MV; Pikija, S; Wass, RE; Bandke, D; Weis, S; Studnicka, M; Grinzinger, S; McCoy, MR; Hauer, L; Sellner, J Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.
Front Immunol. 2018; 9(1): 108-108. Doi: 10.3389/fimmu.2018.00108 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Li, M; Su, Y; Zhang, F; Chen, K; Xu, X; Xu, L; Zhou, J; Wang, W A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Acta Biomater. 2018; 75(10):413-426 Doi: 10.1016/j.actbio.2018.05.049
Web of Science PubMed FullText FullText_MUG

 

Li, M; Zhang, F; Su, Y; Zhou, J; Wang, W Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Life Sci. 2018; 201(10):37-44 Doi: 10.1016/j.lfs.2018.03.044
Web of Science PubMed FullText FullText_MUG

 

Ma, YT; Yang, Y; Cai, P; Sun, DY; Sánchez-Murcia, PA; Zhang, XY; Jia, WQ; Lei, L; Guo, M; Gago, F; Wang, H; Fang, WS A Series of Enthalpically Optimized Docetaxel Analogues Exhibiting Enhanced Antitumor Activity and Water Solubility.
J Nat Prod. 2018; 81(3):524-533 Doi: 10.1021/acs.jnatprod.7b00857
Web of Science PubMed FullText FullText_MUG

 

Menzer, C; Beedgen, B; Rom, J; Duffert, CM; Volckmar, AL; Sedlaczek, O; Richtig, E; Enk, A; Jäger, D; Hassel, JC Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.
Eur J Cancer. 2018; 104(2):239-242 Doi: 10.1016/j.ejca.2018.09.008 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Mutgan, AC; Besikcioglu, HE; Wang, S; Friess, H; Ceyhan, GO; Demir, IE Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.
Mol Cancer. 2018; 17(1):66-66 Doi: 10.1186/s12943-018-0806-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148 Doi: 10.1016/j.ejca.2017.11.008 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Tsibulak, I; Wieser, V; Degasper, C; Shivalingaiah, G; Wenzel, S; Sprung, S; Lax, SF; Marth, C; Fiegl, H; Zeimet, AG BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Br J Cancer. 2018; 119(6):683-692 Doi: 10.1038/s41416-018-0217-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum